| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.006 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.008 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |